Heterocyclic compounds form the backbone of countless pharmaceuticals, offering diverse structural motifs that are key to biological activity. Within this vast chemical landscape, 5-(2-sulfanylidene-3H-1,3-thiazol-4-yl)thiophene-2-carboxamide (CAS 52560-89-1) stands out as a valuable intermediate, particularly in the pharmaceutical industry. Its unique structure, combining thiophene and thiazole rings, makes it a sought-after component for synthesizing complex drug molecules.

The compound's molecular formula is C8H6N2OS3, with a molecular weight of 242.34. As a pale yellow powder, it is readily identifiable and manageable in chemical synthesis processes. Its primary application is in the multi-step synthesis of Arotinolol hydrochloride, a vital medication used to treat cardiovascular conditions. The precise chemical architecture of 5-(2-sulfanylidene-3H-1,3-thiazol-4-yl)thiophene-2-carboxamide ensures the correct formation of the final API, highlighting the importance of sourcing it from reliable manufacturers.

NINGBO INNO PHARMCHEM CO.,LTD., a prominent supplier based in China, specializes in providing high-quality pharmaceutical intermediates. We understand the critical need for purity and consistency in this sector. Our commitment to these standards means that when you buy 5-(2-sulfanylidene-3H-1,3-thiazol-4-yl)thiophene-2-carboxamide from us, you are assured of a product with high purity levels, suitable for demanding pharmaceutical synthesis applications. We actively contribute to the sector of API building blocks by ensuring the reliable availability of such essential compounds.

The intricate nature of heterocyclic chemistry opens doors for innovation in drug discovery. 5-(2-Sulfanylidene-3H-1,3-thiazol-4-yl)thiophene-2-carboxamide serves not only as an intermediate but also as a potential starting point for further chemical exploration. For researchers and manufacturers focused on advancing cardiovascular therapies or exploring new heterocyclic scaffolds, partnering with NINGBO INNO PHARMCHEM CO.,LTD. ensures access to critical materials and expertise in pharmaceutical intermediate synthesis.